Free HRT Protocols & Medication Management Questions and Answers

Question 1

What is the main advantage of transdermal estrogen therapy over oral estrogen?

Accepted Answer

Bypasses hepatic first-pass effect

Answer

Transdermal estrogen therapy delivers estrogen directly into the bloodstream through the skin, bypassing the hepatic first-pass metabolism that occurs with oral estrogen. This route reduces the impact on clotting factors and other liver-produced proteins. Bypassing the liver can potentially lower the risk of certain side effects associated with oral estrogen.

Question 2

What is the primary reason to prescribe progesterone with estrogen in HRT for women with a uterus?

Accepted Answer

Prevent endometrial hyperplasia

Answer

In women with an intact uterus, estrogen therapy alone can stimulate the growth of the uterine lining (endometrium), leading to endometrial hyperplasia and an increased risk of endometrial cancer. Progesterone is prescribed concurrently to counteract this effect, causing the endometrium to shed or mature. This is a critical safety measure in HRT for these patients.

Question 3

Which hormone therapy is typically used for males with hypogonadism?

Accepted Answer

Testosterone therapy

Answer

Hypogonadism in males is characterized by insufficient testosterone production. The primary treatment for this condition is testosterone replacement therapy (TRT), which aims to restore testosterone levels to a normal physiological range. This helps alleviate symptoms such as low libido, fatigue, and muscle weakness associated with testosterone deficiency.

Question 4

What is a common side effect of testosterone therapy in men?

Accepted Answer

Polycythemia

Answer

Polycythemia, an increase in red blood cell count and hematocrit, is a common and well-documented side effect of testosterone therapy in men. Testosterone can stimulate erythropoiesis (red blood cell production), leading to thicker blood. This condition requires monitoring as it can increase the risk of cardiovascular events like blood clots.

Question 5

How often should patients on HRT be monitored for hormone levels?

Accepted Answer

Every 3–6 months

Answer

Regular monitoring of hormone levels is crucial for patients on HRT to ensure therapeutic efficacy and safety. Once stable, monitoring every 3-6 months allows clinicians to assess hormone levels, evaluate symptom control, and detect potential side effects or imbalances. This frequency helps maintain optimal treatment while minimizing patient burden.

HRT - Hormone Replacement Therapy Certification Practice Test

HRT - Hormone Replacement Therapy Certification Practice Test

Free HRT Protocols & Medication Management Questions and Answers